UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 155

Sortiert nach

The association of miR-126-3p, miR-126-5p and miR-664-3p expression profiles with outcomes of patients with metastatic colorectal cancer treated with bevacizumab

Tumor biology, 2017-07, Vol.39 (7), p.1010428317709283-1010428317709283

2017

Volltextzugriff (PDF)

Detection and Quantification of ctDNA for Longitudinal Monitoring of Treatment in Non-Small Cell Lung Cancer Patients Using a Universal Mutant Detection Assay by Denaturing Capillary Electrophoresis

Pathology oncology research, 2022-06, Vol.28, p.1610308-1610308

2022

Volltextzugriff (PDF)

Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study

Cancer Immunology, Immunotherapy, 2023-09, Vol.72 (9), p.2961-2970

2023

Volltextzugriff (PDF)

Impact of Delaying the Addition of Anti-EGFR in First Line of RAS Wild-Type Metastatic Colorectal Cancer: A Propensity-Weighted Pooled Data Analysis

Cancers, 2022-03, Vol.14 (6), p.1410

2022

Volltextzugriff (PDF)

Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry

BMC cancer, 2017-12, Vol.17 (1), p.880-880, Article 880

2017

Volltextzugriff (PDF)

Complex molecular profile of DNA repair genes in epithelial ovarian carcinoma patients with different sensitivity to platinum-based therapy

Frontiers in oncology, 2022-12, Vol.12, p.1016958-1016958

2022

Volltextzugriff (PDF)

Cytoreductive Nephrectomy and Overall Survival of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy—Data from the National Renis Registry

Cancers, 2020-10, Vol.12 (10), p.2911

2020

Volltextzugriff (PDF)

Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study

Targeted oncology, 2023-07, Vol.18 (4), p.559-570

2023

Volltextzugriff (PDF)

Outcomes According to MSKCC Risk Score with Focus on the Intermediate-Risk Group in Metastatic Renal Cell Carcinoma Patients Treated with First-Line Sunitinib: A Retrospective Analysis of 2390 Patients

Cancers, 2020-03, Vol.12 (4), p.808

2020

Volltextzugriff (PDF)

Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1)

Clinical genitourinary cancer, 2023-10, Vol.21 (5), p.e309-e319.e1

2023

Volltextzugriff (PDF)

Parkin (PARK 2) mutations are rare in Czech patients with early-onset Parkinson's disease

PloS one, 2014-09, Vol.9 (9), p.e107585

2014

Volltextzugriff (PDF)

Sequential Treatment with Bevacizumab and Aflibercept for Metastatic Colorectal Cancer in Real-World Clinical Practice

Targeted oncology, 2020-04, Vol.15 (2), p.193-201

2020

Volltextzugriff (PDF)

Thyroid transcription factor 1 expression is associated with outcome of patients with non-squamous non-small cell lung cancer treated with pemetrexed-based chemotherapy

Tumor biology, 2017-02, Vol.39 (2), p.1010428317691186-1010428317691186

2017

Volltextzugriff (PDF)

Targeted panel sequencing of pharmacogenes and oncodrivers in colorectal cancer patients reveals genes with prognostic significance

Human genomics, 2024-07, Vol.18 (1), p.1-15, Article 83

2024

Volltextzugriff (PDF)

Prognostic potential of whole exome sequencing in the clinical management of metachronous colorectal cancer liver metastases

Cancer cell international, 2023-11, Vol.23 (1), p.1-295, Article 295

2023

Volltextzugriff (PDF)

Simulation, modelling and delay estimation in Profinet networks

2015 IEEE 20th Conference on Emerging Technologies & Factory Automation (ETFA), 2015, p.1-7

2015

Volltextzugriff (PDF)

Concomitant antihypertensive medication and outcome of patients with metastatic castration‐resistant prostate cancer receiving enzalutamide or abiraterone acetate

Cancer medicine (Malden, MA), 2024-01, Vol.13 (1), p.e6853-n/a

2024

Volltextzugriff (PDF)

Circulating Tumor Cell Kinetics and Morphology from the Liquid Biopsy Predict Disease Progression in Patients with Metastatic Colorectal Cancer Following Resection

Cancers, 2022-01, Vol.14 (3), p.642

2022

Volltextzugriff (PDF)

Efficacy of everolimus in second- and third-line therapy for metastatic renal cell carcinoma: A registry-based analysis

Urologic oncology, 2014-07, Vol.32 (5), p.569-575

2014

Volltextzugriff (PDF)

Immune-related Adverse Effects and Outcome of Patients With Cancer Treated With Immune Checkpoint Inhibitors

Anticancer research, 2020-03, Vol.40 (3), p.1219-1227

2020

Volltextzugriff (PDF)

Impact of Concomitant Cardiovascular Medication on Survival of Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib or Pazopanib in the First Line

Targeted oncology, 2021-09, Vol.16 (5), p.643-652

2021

Volltextzugriff (PDF)

Pembrolizumab in patients with advanced upper tract urothelial carcinoma: a real-world study from ARON-2 project

Clinical & experimental metastasis, 2024-06

2024

Volltextzugriff (PDF)

Exome Sequencing of Paired Colorectal Carcinomas and Synchronous Liver Metastases for Prognosis and Therapy Prediction

JCO precision oncology, 2023-05, Vol.7, p.e2200557

2023

Volltextzugriff (PDF)

1 – 25 von 155

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(143)
Mit Volltextzugriff
(148)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

The association of miR-126-3p, miR-126-5p and miR-664-3p expression profiles with outcomes of patients with metastatic colorectal cancer treated with bevacizumab

Detection and Quantification of ctDNA for Longitudinal Monitoring of Treatment in Non-Small Cell Lung Cancer Patients Using a Universal Mutant Detection Assay by Denaturing Capillary Electrophoresis

Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study

Impact of Delaying the Addition of Anti-EGFR in First Line of RAS Wild-Type Metastatic Colorectal Cancer: A Propensity-Weighted Pooled Data Analysis

Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry

Complex molecular profile of DNA repair genes in epithelial ovarian carcinoma patients with different sensitivity to platinum-based therapy

Bone targeting agents, but not radiation therapy, improves survival in patients with bone metastases from advanced urothelial carcinoma receiving pembrolizumab: results from the ARON-2 study

Cytoreductive Nephrectomy and Overall Survival of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy—Data from the National Renis Registry

Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study

Outcomes According to MSKCC Risk Score with Focus on the Intermediate-Risk Group in Metastatic Renal Cell Carcinoma Patients Treated with First-Line Sunitinib: A Retrospective Analysis of 2390 Patients

Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1)

Parkin (PARK 2) mutations are rare in Czech patients with early-onset Parkinson's disease

Sequential Treatment with Bevacizumab and Aflibercept for Metastatic Colorectal Cancer in Real-World Clinical Practice

Thyroid transcription factor 1 expression is associated with outcome of patients with non-squamous non-small cell lung cancer treated with pemetrexed-based chemotherapy

Targeted panel sequencing of pharmacogenes and oncodrivers in colorectal cancer patients reveals genes with prognostic significance

Prognostic potential of whole exome sequencing in the clinical management of metachronous colorectal cancer liver metastases

Simulation, modelling and delay estimation in Profinet networks

Concomitant antihypertensive medication and outcome of patients with metastatic castration‐resistant prostate cancer receiving enzalutamide or abiraterone acetate

Circulating Tumor Cell Kinetics and Morphology from the Liquid Biopsy Predict Disease Progression in Patients with Metastatic Colorectal Cancer Following Resection

Efficacy of everolimus in second- and third-line therapy for metastatic renal cell carcinoma: A registry-based analysis

Immune-related Adverse Effects and Outcome of Patients With Cancer Treated With Immune Checkpoint Inhibitors

Impact of Concomitant Cardiovascular Medication on Survival of Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib or Pazopanib in the First Line

External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations

Pembrolizumab in patients with advanced upper tract urothelial carcinoma: a real-world study from ARON-2 project

Exome Sequencing of Paired Colorectal Carcinomas and Synchronous Liver Metastases for Prognosis and Therapy Prediction

Suchergebnisse filtern